Peripheral Arterial Diseases Clinical Trial
Official title:
A Study of Patients' Perspectives of Factors That Support the Management of Cardiac Care for Improved Outcomes in a Peripheral Arterial Disease Population
Specific Aims: To delve into the complex phenomena of living with Peripheral Arterial
Disease (PAD), and to investigate the patients' perspective of the factors that affects
their decisions regarding management of their PAD.
a) Utilize a qualitative approach to uncover factors that patients perceive support the
management of their condition utilizing a purposive sampling of Peripheral Arterial Disease
patients.
1. To determine what they believe to be effective tools to support themselves to improve
their condition.
2. To determine from the patient's perspective if adherence to prescribed medical regimes
are important for them to improve their PAD outcomes.
3. To describe the patient factors of those who are self reported adherent compared to
those who are not or unable to their prescribed regimen.
Cardiovascular Diseases (CVD) affects as many lives each year as cancer, chronic lower
respiratory diseases, accidents and diabetes mellitus combined. One in three American adults
(about 80,000,000) has one or more types of cardiovascular disease. Prevention and
management of CVD is a public health goal, yet, it remains a major challenge. Even
hypertension, which is easily detected and usually controllable, has only a 50 percent
control rate.
Peripheral Arterial Disease (PAD) is one type of CVD, which affects about eight million
Americans and is also associated with significant morbidity and mortality. PAD increases
with age and disproportionately affects African Americans. Interestingly, despite its
prevalence and cardiovascular risk implications, only 20 to 30 percent of PAD patients are
undergoing treatment.
Medical management of these diseases has substantially contributed to improved morbidity and
mortality. However, for the medical therapies to be successful the patients need to take
their medications and adjust their lifestyles, as prescribed. Overall, "typical adherence
rates for the general population are about 50 percent for medications and are much lower for
lifestyle prescriptions and other more behaviorally demanding regimens". Few studies have
investigated the reactions and thoughts regarding the efficacy of therapies/interventions
from the perspective of the participants. Meta analyses on adherence have also revealed that
the patients' perspectives are often absent and that present adherence theories are more
successful in explaining non-adherence than improving adherence. Therefore, it is important
to understand, from the perspective of the patient; the factors they believe improve their
cardiac outcomes with an emphasis on the adherence to prescribed therapies.
This qualitative study will investigate the question: What are patients' perspectives of
factors that support the management of their cardiovascular condition to improve outcomes in
a Peripheral Arterial Disease population? Cardiac outcomes of interest are health status
defined by symptom burden, functional status, and health related quality of life, patients'
perception of the quality of care that they receive, and the experience of living with PAD.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02041169 -
Lower Extremity Peripheral Arterial Disease and Exercise Ischemia
|
N/A | |
Completed |
NCT01436435 -
The Jetstream (JET) Post-market Registry
|
Phase 4 | |
Completed |
NCT01983449 -
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
|
Phase 4 | |
Completed |
NCT03469349 -
Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB
|
Phase 3 | |
Completed |
NCT00640770 -
Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease
|
Phase 4 | |
Recruiting |
NCT05192707 -
Transcutaneous Oxygen Pressure (TcPO2) Determination.
|
||
Withdrawn |
NCT02531139 -
The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery
|
N/A | |
Completed |
NCT00652418 -
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
|
Phase 2 | |
Completed |
NCT02920125 -
Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
|
Phase 3 | |
Completed |
NCT02273232 -
Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial
|
Phase 1 | |
Completed |
NCT01952756 -
Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)
|
Phase 4 | |
Completed |
NCT02066740 -
EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study
|
N/A | |
Completed |
NCT01336101 -
Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
|
N/A |